IP Library Granted Patent US 8,617,530
Granted Patent B2
US 8,617,530 · App. 13/689,640 · Granted Dec 31, 2013

Polymer conjugates of opioid antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,530
App. No.
13/689,640
Granted
Dec 31, 2013
Kind
B2
Abstract

The invention provides polymer conjugates of opioid antagonists comprising a polymer, such as poly(ethylene glycol), covalently attached to an opioid antagonist. The linkage between the polymer and the opioid antagonist is preferably hydrolytically stable. The invention also includes a method of treating one or more side effects associated with the use of opioid analgesics, such as constipation, nausea, or pruritus, by administering a polymer conjugate of the invention.

Claims (29)

1. A method of treating constipation resulting from the administration of an opioid agonist to a patient in need thereof, said method comprising administering to the patient in need thereof a therapeutically effective amount of a polymer conjugate of the formula:

or pharmaceutically acceptable salt thereof, wherein:

Y is allyl;

Z is OH;

X is —NHC(O)—, —NH—, —OC(O)NH—, —O—, —S— or —NHC(O)NH—; and

POLY is methoxy poly(ethylene glycol), wherein POLY has a molecular weight of from about 100 Da to about 2,000 Da.

2. A method of treating nausea resulting from the administration of an opioid agonist to a patient in need thereof, said method comprising administer to the patient in need thereof a therapeutically effective amount of a polymer conjugate of the formula:

or pharmaceutically acceptable salt thereof, wherein:

Y is allyl;

Z is OH:

X is —NHC(O)—, —NH—, —OC(O)NH—, —O—, —S— or —NHC(O)NH—; and

POLY is methoxy poly(ethylene glycol), wherein POLY has a molecular weight of from about 100 Da to about 2.000 Da.

3. A method of treating pruritus resulting from the administration of an opioid agonist to a patient in need thereof, said method comprising administering to the patient in need thereof a therapeutically effective amount of a polymer conjugate of the formula:

or pharmaceutically acceptable salt thereof, wherein:

Y is allyl;

Z is OH;

X is —NHC(O)—, —NH—, —OC(O)NH—, —O—, —S— or —NHC(O)NH—; and

POLY is methoxy poly(ethylene glycol), wherein POLY has a molecular weight of from about 100 Da to about 2,000 Da.

4. The method of claim 1 , wherein POLY has the formula:

CH 3 O—(CH 2 CH 2 O) n —CH 2 CH 2 —,

wherein n is from 2 to 45.

5. The method of claim 4 , wherein n is from 2 to 20.

6. The method of claim 1 , wherein POLY has a molecular weight of from about 100 Da to about 500 Da.

7. The method of claim 1 , wherein X is —NHC(O)—.

8. The method of claim 1 , wherein X is —NH—.

9. The method of claim 1 , wherein X is —OC(O)NH—.

10. The method of claim 1 , wherein X is —O—.

11. The method of claim 1 , wherein X is —S—.

12. The method of claim 1 , wherein X is —NHC(O)NH—.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 19, 2024
From: HCR REDHILL SPV, LLC
To: REDHILL BIOPHARMA INC.; REDHILL BIOPHARMA LTD.
Reel/Frame 068034/0458 →
SECURITY INTEREST Recorded Feb 24, 2020
From: REDHILL BIOPHARMA INC.
To: HCR COLLATERAL MANAGEMENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 051909/0460 →
MERGER Recorded Mar 12, 2015
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 035155/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: BENTLEY, MICHAEL DAVID; ROBERTS, MICHAEL JAMES; SHEN, XIAOMING; CHENG, LIN
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 035155/0763 →